Antibody avidity-based approach to estimate population-level incidence of hepatitis C

Accurate HCV incidence estimates are critical for monitoring progress towards HCV elimination goals, including an 80% reduction in HCV incidence by 2030. Moreover, incidence estimates can help guide prevention and treatment programming, particularly in the context of the US opioid epidemic. An inexp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepatology 2020-08, Vol.73 (2), p.294-302
Hauptverfasser:	Boon, Denali, Bruce, Veronica, Patel, Eshan U., Quinn, Jeffrey, Srikrishnan, Aylur K., Shanmugam, Saravanan, Iqbal, Syed, Balakrishnan, Pachamuthu, Sievers, Matthew, Kirk, Gregory D., Thomas, David L., Quinn, Thomas C., Cox, Andrea L., Page, Kimberly A., Solomon, Sunil S., Mehta, Shruti H., Laeyendecker, Oliver
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Avidity CD4 antigen Genotypes HCV Hepatitis Hepatitis C HIV HIV/HCV coinfection Human immunodeficiency virus Immunoglobulin G Incidence Infections Opioids Population Recent infection Ribonucleic acid RNA Seroconversion Surveillance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!